PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
NCT05303714
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
98
Enrollment
OTHER
Sponsor class
Conditions
Oligometastatic Gastric Adenocarcinoma
Interventions
COMBINATION_PRODUCT:
FOLFOX and PIPAC
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona